经颅直流电刺激对脑卒中慢性肩痛的疗效及机制研究

注册号:

Registration number:

ChiCTR2200056970 

最近更新日期:

Date of Last Refreshed on:

2022-10-19 19:53:38 

注册时间:

Date of Registration:

2022-02-25 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

经颅直流电刺激对脑卒中慢性肩痛的疗效及机制研究

Public title:

Effect and mechanism of transcranial direct current stimulation on stroke patients with chronic shoulder pain

注册题目简写:

English Acronym:

研究课题的正式科学名称:

经颅直流电刺激对脑卒中慢性肩痛的疗效及机制研究

Scientific title:

Effect and mechanism of transcranial direct current stimulation on stroke patients with chronic shoulder pain

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

李玉 

研究负责人:

李玉 

Applicant:

Yu Li 

Study leader:

Yu Li 

申请注册联系人电话:

Applicant telephone:

+86 18305925597

研究负责人电话:

Study leader's
telephone:

+86 18305925597

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

1397556070@qq.com

研究负责人电子邮件:

Study leader's E-mail:

1397556070@qq.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

福建医科大学附属第一医院

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

福建省福州市茶中路20号

研究负责人通讯地址:

福建省福州市茶中路20号

Applicant address:

Room 404, Building 9, Faculty Dormitory, Hetang Road, Taijiang District, Fuzhou, Fujian

Study leader's address:

20 Chazhong Road, Fuzhou, Fujian, China

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

福建医科大学附属第一医院

Applicant's institution:

The First Affiliated Hospital of Fujian Medical University

研究负责人所在单位:

福建医科大学附属第一医院

Affiliation of the Leader:

The First Affiliated Hospital of Fujian Medical University

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

MRCTA,ECFAH of FMU [2020]269

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

福建医科大学第一附属医院伦理委员会研究与临床技术应用分会伦理评论

Name of the ethic committee:

Ethics Review From for Branch for Medical Research and Clinical Technology Application, Ethics Committee of First Affiliated Hospital of Fujian Medical University

伦理委员会批准日期:

Date of approved by ethic committee:

2020-06-22 00:00:00

伦理委员会联系人:

王柠

Contact Name of the ethic committee:

Ning Wang

伦理委员会联系地址:

福建省福州市茶中路20号

Contact Address of the ethic committee:

20 Chazhong Road, Fuzhou, Fujian, China

伦理委员会联系人电话:

Contact phone of the ethic committee:

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

福建医科大学附属第一医院

Primary sponsor:

The First Affiliated Hospital of Fujian Medical University

研究实施负责(组长)单位地址:

福建省福州市茶中路20号

Primary sponsor's address:

20 Chazhong Road, Fuzhou, Fujian, China

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

福建

市(区县):

福州

Country:

China

Province:

Fujian

City:

Fuzhou

单位(医院):

福建医科大学附属第一医院

具体地址:

茶中路20号

Institution
hospital:

The First Affiliated Hospital of Fujian Medical University

Address:

20 Chazhong Road

经费或物资来源:

福建医科大学启航基金项目(2019QH1086)

Source(s) of funding:

Startup Fund for Scientific Research, Fujian Medical University (2019QH1086, Fuzhou)

研究疾病:

脑卒中  

Target disease:

Stroke

研究疾病代码:

Target disease code:

研究类型:

干预性研究

Study type:

Interventional study

研究所处阶段:

探索性研究/预试验 

Study phase:

0

研究设计:

随机平行对照 

Study design:

Parallel 

研究目的:

本研究目的是评价a-tDCS联合常规康复治疗对脑卒中偏瘫肩痛患者疼痛水平和功能改善的影响。此外将通过感觉神经阈值定量检测(CPT),并结合头部功能磁共振和肩部磁共振平扫等影像学检查进一步探讨卒中后肩痛的发展机制。  

Objectives of Study:

The purpose of this study was to evaluate the effects of A-TDCS combined with routine rehabilitation on pain level and functional improvement in stroke patients with hemiplegic shoulder pain. In addition, the developmental mechanism of shoulder pain after stroke will be further explored by quantitative detection of sensory nerve threshold (CPT), combined with imaging examinations such as functional magnetic resonance of the head and plain magnetic resonance of the shoulder.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

Inclusion criteria

排除标准:

1. 头部外伤史;
2. 神经退行性疾病;
3. 严重感觉障碍;
4. 诊断为肩周炎;
5. 诊断为严重精神病,或滥用药物;
6. 非侵入性脑刺激禁忌症(应用部位附近的金属植入物、癫痫和/或癫痫病史、妊娠、肿瘤诊断);
7. 合并上肢骨折;
8. 合并糖尿病。

Exclusion criteria:

1. History of head trauma;
2. Neurodegenerative diseases;
3. Severe sensory impairment;
4. Periarthritis of shoulder was diagnosed;
5. Diagnosis of severe mental illness, or substance abuse;
6. Contraindications to non-invasive brain stimulation (metal implants near the application site, history of epilepsy and/or epilepsy, pregnancy, tumor diagnosis);
7. Combined with upper limb fracture;
8. Diabetes mellitus.

研究实施时间:

Study execute time:

From 2020-04-01 00:00:00 To 2023-04-30 00:00:00  

征募观察对象时间:

Recruiting time:

From 2022-03-07 00:00:00 To 2023-04-30 00:00:00

干预措施:

Interventions:

组别:

实验组

样本量:

20

Group:

Experimental group

Sample size:

干预措施:

经颅直流电刺激

干预措施代码:

Intervention:

tDCS

Intervention code:

组别:

对照组

样本量:

20

Group:

Control group

Sample size:

干预措施:

干预措施代码:

Intervention:

NA

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

福建 

市(区县):

 

Country:

China

Province:

Fujian

City:

单位(医院):

福建医科大学附属第一医院 

单位级别:

三甲 

Institution
hospital:

The First Affiliated Hospital of Fujian Medical University

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

电流感觉阈值(CPT)

指标类型:

主要指标

Outcome:

Current perception threshold

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

疼痛视觉模拟评分

指标类型:

主要指标

Outcome:

Visual analogue score, VAS

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

生活质量

指标类型:

次要指标

Outcome:

Quality of Life, QOL

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

焦虑抑郁量表

指标类型:

次要指标

Outcome:

Hospital anxiety and depression scale, HADS

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

疼痛耐受阈值(PTT)

指标类型:

主要指标

Outcome:

Pain tolerance threshold

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

征募研究对象情况:

Recruiting status:

正在进行

Recruiting

年龄范围:

Participant age:

最小 Min age 18 years
最大 Max age 80 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

采用随机数字表法将患者连续分为实验组及对照组。

Randomization Procedure (please state who generates the random number sequence and by what method):

Patients were divided into experimental group and control group by random number table method.

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

Blinding:

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

是Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

提供数据给期刊

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

Provide the date to journals

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

病例记录表

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Case Record Form

数据与安全监察委员会:

Data and Safety Monitoring Committee:

有/Yes

注册人:

Name of Registration:

 2022-02-25 06:36:10